Developer docs
API playgroundTry for free, no card

Search company profiles

Zymtronix

Full company profile

uuid0002qg9

Namestring
Zymtronix
Legal namestring
Zymtronix Catalytic Systems, Inc.
Websiteurl
zymtronix.com
Company typeenum
Private
Founded yearint
2013
Descriptiontext

Zymtronix is a pre-commercial-stage biotechnology company that develops a patented, cell-free enzyme biocatalysis platform originating from Cornell University research. The company eliminates the need for living cells, enabling production of complex molecules that cannot be made through traditional fermentation while improving production economics via a lower equipment footprint, reusable enzyme carriers, and simplified downstream processing. Its technology portfolio comprises three branded platforms: Crop-Core (agriculture), EX Enzyme Technology (herbicide enhancement), and Carbo Core (complex molecule production including human milk oligosaccharides).

The company commercializes across three product lines. In agriculture, it is developing BioEnhanced Herbicides (using EX Enzyme Technology to increase herbicide translocation and extend performance), Biofungicides (fast-acting antimicrobial compounds for targeted disease control), and Seed and Post-Harvest Sanitizers; commercialization of EX for vegetation management is planned for 2026-2027 under an exclusive partnership with The Orion Companies. In nutrition, Zymtronix commercially offers DSLNT (Disialyllacto-N-tetraose), a complex human milk oligosaccharide, to researchers and industrial partners. The company also operates an enzyme services platform for food, agriculture, cosmetics, and pharmaceutical ingredient production, in collaboration with Ginkgo Bioworks.

Zymtronix's business model combines pre-commercial product development with quote-based direct sales (DSLNT), exclusive channel partnerships (Orion for vegetation management), and a co-development relationship with Ginkgo Bioworks for upstream enzyme optimization. The company is venture-backed, has raised approximately $4.88M across six disclosed funding rounds through 2021 (with NSF as lead investor in early rounds), and is led by CEO Adam Monroe (former Novozymes President for North America) with founder Stéphane Corgié serving as Chief Innovation Officer. The company is headquartered in Durham, North Carolina, with research roots in Ithaca, New York.

Short descriptiontext

Zymtronix is a pre-commercial-stage biotechnology company that develops a patented cell-free enzyme biocatalysis platform originating from Cornell University, serving the agriculture (bioenhanced herbicides, biofungicides, sanitizers), nutrition (human milk oligosaccharides like DSLNT), and industrial biomanufacturing markets through direct sales and exclusive partnerships.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersDurham, United States
HQ citystring
Durham
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
cell-free biocatalysis, enzyme immobilization technology, agricultural biotechnology products, human milk oligosaccharides, sustainable biomanufacturing
Industry3 codes
PRIMARYEUAAAIAL
Enzymes & Industrial Biotechnology Inputs (Enzymes, Microbial Strains, Fermentation Aids)
Energy, Utilities & Environment/Bioenergy, Natural Gas & Biomass/Biorefining & Bio-based Chemicals (Co-products, Bioproducts)
SECONDARYAFABAEAM
Biological Formulation, Fermentation & Scale-Up Manufacturing
Agriculture & Food Production/Agricultural Inputs & Agrochemicals/Biologicals & Biopesticides (Microbials, Botanicals, Beneficial Insects)
SECONDARYEUAAAIAK
Bio-based Pharmaceuticals, Nutraceuticals & Specialty Bioactives
Energy, Utilities & Environment/Bioenergy, Natural Gas & Biomass/Biorefining & Bio-based Chemicals (Co-products, Bioproducts)
NAICS code3 codes
  • Medicinal and Botanical Manufacturing325411
  • Pesticide, Fertilizer, and Other Agricultural Chemical Manufacturing3253
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
SIC code2 codes
  • Biological Products, (No Disgnostic Substances)2836
  • Services-Commercial Physical & Biological Research8731
Product category
Industrial Biotechnology
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model3 records
1Agricultural Products
TypeOne Time License
Description

Pre-commercial stage company developing and preparing to commercialize BioEnhanced Herbicides, BioFungicides, and Seed and Post-Harvest Sanitizers for the agriculture market. Revenue expected from product sales to farmers and agricultural companies.

zymtronix.com
2Human Milk Oligosaccharides
TypeOne Time License
Description

Commercial sales of DSLNT (Disialyllacto-N-tetraose) to researchers and industrial partners. Zymtronix now offers an economically viable and commercially available source of complex HMOs, selling directly to research institutions and companies.

zymtronix.com
3Technology Licensing
TypeLicensing Royalties
Description

Exclusive partnership with The Orion Companies for development and commercialization of EX enzyme technology in vegetation management uses (industrial vegetation management, forestry, range & pasture). Expected commercialization in 2026-2027.

zymtronix.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Marketing or Sales, Infrastructure, Supply Chain
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 2 records shown
1Crop-Core
Description

The company's enzyme system that enables delivery of BioEnhanced Herbicides, BioFungicides, and Seed and Post-Harvest Sanitizers.

zymtronix.com
+1 more record
Core offering1 text field

Zymtronix develops and commercializes a proprietary cell-free, multi-enzyme biocatalysis platform that produces high-value industrial molecules without living cells, bypassing the limits of traditional fermentation. The platform underpins three product lines: BioEnhanced Herbicides and Biofungicides for agriculture, Seed and Post-Harvest Sanitizers, and complex Human Milk Oligosaccharides (notably DSLNT) for nutrition and microbiome research. The company also licenses its patented EX Enzyme Technology to commercial partners such as The Orion Companies for vegetation management.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • Weeds cause over $55 billion in crop losses each year
+3 more records
Product overview1 text field

Zymtronix is a pre-commercial biotechnology company that offers a proprietary cell-free enzyme platform technology (Cell-Free Biocatalysis Platform) that overcomes traditional fermentation limitations. The platform is powered by the Crop-Core enzyme system and produces high-value industrial products across three main product lines: BioEnhanced Herbicides (using EX Enzyme Technology for enhanced weed control), Biofungicides (for targeted disease control), and Human Milk Oligosaccharides (HMOs including DSLNT) for nutrition applications. The company also offers Seed and Post-Harvest Sanitizers as part of its agricultural solutions portfolio.

Product and service5 records
1Cell-Free Biocatalysis Platform
CategoryBiocatalysis platform technology
Description

Proprietary cell-free enzyme platform that enables efficient production of high-value industrial molecules without living cells, overcoming the productivity, precision, and capital-cost limitations of traditional fermentation. Offered to industrial partners and researchers for co-development and licensing across food, agriculture, cosmetics, and pharmaceutical applications.

2BioEnhanced Herbicides
CategoryAgricultural crop protection products
Description

Herbicide products that enhance traditional active ingredients with proprietary enzyme systems (Crop-Core / EX Enzyme Technology) to provide long-lasting, broad-spectrum weed control, increased herbicide translocation, extended performance, and improved consistency for conventional and organic growers.

3Biofungicides
CategoryAgricultural crop protection products
Description

Enzyme-centered crop protection products that deliver fast-acting antimicrobial compounds to plant leaves for targeted, efficacious control of fungal and bacterial pathogens, addressing a critical shortage of effective treatments for organic and specialty crop growers.

4Seed and Post-Harvest Sanitizers
CategoryAgricultural crop protection products
Description

Crop protection products enabled by the Crop-Core enzyme system that protect seeds and harvested crops from pathogens, intended to decrease financial risk and product variability for seed companies and post-harvest handlers.

5Human Milk Oligosaccharides (DSLNT)
CategoryNutrition and biopharma ingredients
Description

Complex human milk oligosaccharides (notably DSLNT / Disialyllacto-N-tetraose) produced via Zymtronix's cell-free biocatalysis platform, supplied to researchers and industrial partners in infant nutrition, microbiome science, and immunology to address a critical supply bottleneck for HMOs.

Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership2 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-12-17
Description

Exclusive agreement to develop and commercialize Zymtronix EX enzyme technology for herbicide application in vegetation management uses (industrial vegetation management, forestry, range & pasture). Companies began vegetation management field trials in 2024 and plan commercialization in 2026 and 2027 following promising results. The Orion Companies provides innovation to improve effectiveness and productivity of their applicator customers.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2023-02-16
Description

Partnership to optimize enzymes used in Zymtronix's proprietary cell-free platform for production of ingredients in food, agriculture, cosmetics, and pharmaceuticals. Ginkgo leverages its enzyme services (discovery, optimization, production) including metagenomic enzyme discovery and improved enzyme expression and production host performance. This partnership accelerates commercialization of cell-free biomanufacturing and sustainable ingredients, starting with alternatives to animal sources.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Peers10 records
TypeDirect peer
Description

Public synthetic biology platform company pursuing cell-free expression, enzyme engineering and biomanufacturing partnerships. Zymtronix's active partner (Feb 2023) and closest peer given overlapping cell-free/biocatalysis ambitions across pharma, food, and agriculture.

TypeBroad incumbent
Description

Global leader in industrial enzymes and microbial bioproducts with deep crop protection and nutrition adjacencies. Zymtronix CEO Adam Monroe and board member Thomas Videbaek came from Novozymes, making it the most directly relevant incumbent benchmark.

TypeDirect peer
Description

Public enzyme engineering company using directed evolution and biocatalysis platforms to produce pharmaceutical, food, and industrial ingredients. Closely comparable cell-free enzyme IP/development model to Zymtronix's core platform.

TypeDirect peer
Description

Agriculture biologicals company developing microbial crop protection products, where board member John Rabby previously served as President and CEO. Closely comparable in the AgTech-biological product category Zymtronix is targeting with Crop-Core.

TypeDirect peer
Description

Peptide-based bioinsecticide company for crop protection; CFO Jessica Vanhoy led its US$82M Series C. Closely comparable as a venture-backed ag-biological company commercializing novel modes of action in crop protection.

TypeDirect peer
Description

Leading microbial nitrogen-fixation company for row crops; pursues commodity-scale agricultural biologicals with channel partnerships analogous to Zymtronix's Orion partnership for vegetation management.

TypeBroad incumbent
Description

Global nutrition/health ingredients major with HMO production (e.g., GlyCare) and industrial enzymes. Relevant comparison for both Zymtronix's DSLNT HMO business and its broader biomanufacturing ambitions.

TypeBroad incumbent
Description

Diversified crop protection and seed major where board member John Rabby previously served as Group VP North America. Relevant scale benchmark for traditional ag-chemical incumbents Zymtronix is differentiating against via enzyme-based biocontrol.

TypeBroad incumbent
Description

Global crop protection and seed major with growing biologicals franchises. Relevant incumbent for the BioEnhanced Herbicides / Biofungicides competitive set and a credible future channel/licensing partner.

10Zymergen (now Ginkgo Bioworks)
TypeEmerging player
Description

Synthetic biology company that has been folded into Ginkgo Bioworks; historically comparable as a platform player pursuing cell-free and engineered-organism routes to industrial bioproducts.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles9 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds6 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Zymtronix

Industrial Biotechnologyzymtronix.com

Zymtronix is a pre-commercial-stage biotechnology company that develops a patented cell-free enzyme biocatalysis platform originating from Cornell University, serving the agriculture (bioenhanced herbicides, biofungicides, sanitizers), nutrition (human milk oligosaccharides like DSLNT), and industrial biomanufacturing markets through direct sales and exclusive partnerships.

What Zymtronix does

Zymtronix is a pre-commercial-stage biotechnology company that develops a patented, cell-free enzyme biocatalysis platform originating from Cornell University research. The company eliminates the need for living cells, enabling production of complex molecules that cannot be made through traditional fermentation while improving production economics via a lower equipment footprint, reusable enzyme carriers, and simplified downstream processing. Its technology portfolio comprises three branded platforms: Crop-Core (agriculture), EX Enzyme Technology (herbicide enhancement), and Carbo Core (complex molecule production including human milk oligosaccharides).

The company commercializes across three product lines. In agriculture, it is developing BioEnhanced Herbicides (using EX Enzyme Technology to increase herbicide translocation and extend performance), Biofungicides (fast-acting antimicrobial compounds for targeted disease control), and Seed and Post-Harvest Sanitizers; commercialization of EX for vegetation management is planned for 2026-2027 under an exclusive partnership with The Orion Companies. In nutrition, Zymtronix commercially offers DSLNT (Disialyllacto-N-tetraose), a complex human milk oligosaccharide, to researchers and industrial partners. The company also operates an enzyme services platform for food, agriculture, cosmetics, and pharmaceutical ingredient production, in collaboration with Ginkgo Bioworks.

Zymtronix's business model combines pre-commercial product development with quote-based direct sales (DSLNT), exclusive channel partnerships (Orion for vegetation management), and a co-development relationship with Ginkgo Bioworks for upstream enzyme optimization. The company is venture-backed, has raised approximately $4.88M across six disclosed funding rounds through 2021 (with NSF as lead investor in early rounds), and is led by CEO Adam Monroe (former Novozymes President for North America) with founder Stéphane Corgié serving as Chief Innovation Officer. The company is headquartered in Durham, North Carolina, with research roots in Ithaca, New York.

Zymtronix firmographics

Firmographics
Name
Zymtronix
Legal name
Zymtronix Catalytic Systems, Inc.
Website
https://zymtronix.com
Company type
Private
Founded year
2013
Operating status
Operating
Headcount range
11–50 employees
Short description
Zymtronix is a pre-commercial-stage biotechnology company that develops a patented cell-free enzyme biocatalysis platform originating from Cornell University, serving the agriculture (bioenhanced herbicides, biofungicides, sanitizers), nutrition (human milk oligosaccharides like DSLNT), and industrial biomanufacturing markets through direct sales and exclusive partnerships.
Ownership category
akta.pro rank

Zymtronix industry classification

Industry
Product category
Industrial Biotechnology
NAICS
Medicinal and Botanical Manufacturing (325411), Pesticide, Fertilizer, and Other Agricultural Chemical Manufacturing (3253), Research and Development in Biotechnology (except Nanobiotechnology) (541714)
SIC
Biological Products, (No Disgnostic Substances) (2836), Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYEUAAAIAL
Enzymes & Industrial Biotechnology Inputs (Enzymes, Microbial Strains, Fermentation Aids)
Energy, Utilities & Environment/Bioenergy, Natural Gas & Biomass/Biorefining & Bio-based Chemicals (Co-products, Bioproducts)
SECONDARYAFABAEAM
Biological Formulation, Fermentation & Scale-Up Manufacturing
Agriculture & Food Production/Agricultural Inputs & Agrochemicals/Biologicals & Biopesticides (Microbials, Botanicals, Beneficial Insects)
SECONDARYEUAAAIAK
Bio-based Pharmaceuticals, Nutraceuticals & Specialty Bioactives
Energy, Utilities & Environment/Bioenergy, Natural Gas & Biomass/Biorefining & Bio-based Chemicals (Co-products, Bioproducts)

Keywords

  • Cell-free biocatalysis
  • Enzyme immobilization technology
  • Agricultural biotechnology products
  • Human milk oligosaccharides
  • Sustainable biomanufacturing

Where Zymtronix is headquartered

Location

Headquarters

HQ city
Durham
HQ country
United States
HQ region
North America

Offices2 records

Markets served

Zymtronix business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Technology or R&D, Marketing or Sales, Infrastructure, Supply Chain

Revenue model

  1. Agricultural Products: Pre-commercial stage company developing and preparing to commercialize BioEnhanced Herbicides, BioFungicides, and Seed and Post-Harvest Sanitizers for the agriculture market. Revenue expected from product sales to farmers and agricultural companies.
  2. Human Milk Oligosaccharides: Commercial sales of DSLNT (Disialyllacto-N-tetraose) to researchers and industrial partners. Zymtronix now offers an economically viable and commercially available source of complex HMOs, selling directly to research institutions and companies.
  3. Technology Licensing: Exclusive partnership with The Orion Companies for development and commercialization of EX enzyme technology in vegetation management uses (industrial vegetation management, forestry, range & pasture). Expected commercialization in 2026-2027.

Go-to-market motion3 records

Distribution channels2 records

Marketing channels4 records

Zymtronix product offering

Product offering

Core offering

Zymtronix develops and commercializes a proprietary cell-free, multi-enzyme biocatalysis platform that produces high-value industrial molecules without living cells, bypassing the limits of traditional fermentation. The platform underpins three product lines: BioEnhanced Herbicides and Biofungicides for agriculture, Seed and Post-Harvest Sanitizers, and complex Human Milk Oligosaccharides (notably DSLNT) for nutrition and microbiome research. The company also licenses its patented EX Enzyme Technology to commercial partners such as The Orion Companies for vegetation management.

Product overview

Zymtronix is a pre-commercial biotechnology company that offers a proprietary cell-free enzyme platform technology (Cell-Free Biocatalysis Platform) that overcomes traditional fermentation limitations. The platform is powered by the Crop-Core enzyme system and produces high-value industrial products across three main product lines: BioEnhanced Herbicides (using EX Enzyme Technology for enhanced weed control), Biofungicides (for targeted disease control), and Human Milk Oligosaccharides (HMOs including DSLNT) for nutrition applications. The company also offers Seed and Post-Harvest Sanitizers as part of its agricultural solutions portfolio.

Differentiator

Problem solved

Functional benefit

Brands

  • Crop-Core: The company's enzyme system that enables delivery of BioEnhanced Herbicides, BioFungicides, and Seed and Post-Harvest Sanitizers.
  • Carbo Core

Products and services

  • Cell-Free Biocatalysis Platform Proprietary cell-free enzyme platform that enables efficient production of high-value industrial molecules without living cells, overcoming the productivity, precision, and capital-cost limitations of traditional fermentation. Offered to industrial partners and researchers for co-development and licensing across food, agriculture, cosmetics, and pharmaceutical applications.
  • BioEnhanced Herbicides Herbicide products that enhance traditional active ingredients with proprietary enzyme systems (Crop-Core / EX Enzyme Technology) to provide long-lasting, broad-spectrum weed control, increased herbicide translocation, extended performance, and improved consistency for conventional and organic growers.
  • Biofungicides Enzyme-centered crop protection products that deliver fast-acting antimicrobial compounds to plant leaves for targeted, efficacious control of fungal and bacterial pathogens, addressing a critical shortage of effective treatments for organic and specialty crop growers.
  • Seed and Post-Harvest Sanitizers Crop protection products enabled by the Crop-Core enzyme system that protect seeds and harvested crops from pathogens, intended to decrease financial risk and product variability for seed companies and post-harvest handlers.
  • Human Milk Oligosaccharides (DSLNT) Complex human milk oligosaccharides (notably DSLNT / Disialyllacto-N-tetraose) produced via Zymtronix's cell-free biocatalysis platform, supplied to researchers and industrial partners in infant nutrition, microbiome science, and immunology to address a critical supply bottleneck for HMOs.

Quantifiable outcome

  • Weeds cause over $55 billion in crop losses each year
  • +3 more outcomes

Companies that use Zymtronix

Customer profile

Named customers1 record

Segments3 records

Ideal customer profiles3 records

Zymtronix technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature5 records

Zymtronix partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered core.

  • The Orion CompaniescoreStrategic or Co-development Partner · 17 December 2025Exclusive agreement to develop and commercialize Zymtronix EX enzyme technology for herbicide application in vegetation management uses (industrial vegetation management, forestry, range & pasture). Companies began vegetation management field trials in 2024 and plan commercialization in 2026 and 2027 following promising results. The Orion Companies provides innovation to improve effectiveness and productivity of their applicator customers.
  • Ginkgo BioworkscoreTechnology or Integration · 16 February 2023Partnership to optimize enzymes used in Zymtronix's proprietary cell-free platform for production of ingredients in food, agriculture, cosmetics, and pharmaceuticals. Ginkgo leverages its enzyme services (discovery, optimization, production) including metagenomic enzyme discovery and improved enzyme expression and production host performance. This partnership accelerates commercialization of cell-free biomanufacturing and sustainable ingredients, starting with alternatives to animal sources.

Scale indicators5 records

Recent moves6 records

Zymtronix competitors and assessment

Company assessment

Direct peers

  • Ginkgo Bioworks: Public synthetic biology platform company pursuing cell-free expression, enzyme engineering and biomanufacturing partnerships. Zymtronix's active partner (Feb 2023) and closest peer given overlapping cell-free/biocatalysis ambitions across pharma, food, and agriculture.
  • Codexis: Public enzyme engineering company using directed evolution and biocatalysis platforms to produce pharmaceutical, food, and industrial ingredients. Closely comparable cell-free enzyme IP/development model to Zymtronix's core platform.
  • AgBiome: Agriculture biologicals company developing microbial crop protection products, where board member John Rabby previously served as President and CEO. Closely comparable in the AgTech-biological product category Zymtronix is targeting with Crop-Core.
  • Vestaron: Peptide-based bioinsecticide company for crop protection; CFO Jessica Vanhoy led its US$82M Series C. Closely comparable as a venture-backed ag-biological company commercializing novel modes of action in crop protection.
  • Pivot Bio: Leading microbial nitrogen-fixation company for row crops; pursues commodity-scale agricultural biologicals with channel partnerships analogous to Zymtronix's Orion partnership for vegetation management.

Broad incumbents

  • Novonesis (formerly Novozymes): Global leader in industrial enzymes and microbial bioproducts with deep crop protection and nutrition adjacencies. Zymtronix CEO Adam Monroe and board member Thomas Videbaek came from Novozymes, making it the most directly relevant incumbent benchmark.
  • dsm-firmenich: Global nutrition/health ingredients major with HMO production (e.g., GlyCare) and industrial enzymes. Relevant comparison for both Zymtronix's DSLNT HMO business and its broader biomanufacturing ambitions.
  • BASF Agricultural Solutions: Diversified crop protection and seed major where board member John Rabby previously served as Group VP North America. Relevant scale benchmark for traditional ag-chemical incumbents Zymtronix is differentiating against via enzyme-based biocontrol.
  • Bayer Crop Science: Global crop protection and seed major with growing biologicals franchises. Relevant incumbent for the BioEnhanced Herbicides / Biofungicides competitive set and a credible future channel/licensing partner.

Emerging players

  • Zymergen (now Ginkgo Bioworks): Synthetic biology company that has been folded into Ginkgo Bioworks; historically comparable as a platform player pursuing cell-free and engineered-organism routes to industrial bioproducts.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Zymtronix social profiles

Digital presence

Zymtronix financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Zymtronix leadership team

Management profile

Number of profiles

Profiles9 records

Zymtronix funding detail

Funding detail

Funding overview

Funding rounds6 records

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Zymtronix M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Zymtronix

What does Zymtronix do?

Zymtronix develops and commercializes a proprietary cell-free, multi-enzyme biocatalysis platform that produces high-value industrial molecules without living cells, bypassing the limits of traditional fermentation. The platform underpins three product lines: BioEnhanced Herbicides and Biofungicides for agriculture, Seed and Post-Harvest Sanitizers, and complex Human Milk Oligosaccharides (notably DSLNT) for nutrition and microbiome research. The company also licenses its patented EX Enzyme Technology to commercial partners such as The Orion Companies for vegetation management.

Is Zymtronix a public or private company?

Zymtronix is a private company. It is classified as venture growth investor backed and is currently operating.

When was Zymtronix founded?

Zymtronix was founded in 2013. It employs 11 to 50 people.

Where is Zymtronix based?

Zymtronix is headquartered in Durham, United States, in the North America region.

How does Zymtronix make money?

Three revenue lines are on record. Agricultural Products are the primary driver. The others are human Milk Oligosaccharides and technology Licensing.

Who are Zymtronix's main competitors?

Direct peers on record are Ginkgo Bioworks, Codexis, AgBiome, Vestaron and Pivot Bio. Broad incumbents are Novonesis (formerly Novozymes), dsm-firmenich, BASF Agricultural Solutions and Bayer Crop Science. Zymergen (now Ginkgo Bioworks) is listed as an emerging player.

Does Zymtronix have an API?

No public API is recorded for Zymtronix.

What industry is Zymtronix in?

Zymtronix's product category is Industrial Biotechnology. Its primary akta.pro industry code is EUAAAIAL, Enzymes & Industrial Biotechnology Inputs (Enzymes, Microbial Strains, Fermentation Aids), with a secondary code of AFABAEAM, Biological Formulation, Fermentation & Scale-Up Manufacturing. Its NAICS code is 325411 and its SIC code is 2836.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswireZymtronix and Ginkgo Bioworks Announce Partnership to Produce Enzymes for the Industrialization of Cell-Free BiomanufacturingZymtronix and Ginkgo Bioworks announced a partnership to optimize enzymes for Zymtronix's cell-free platform, aiming to produce ingredients for food, agriculture, cosmetics, and pharmaceuticals. Ginkgo will use its enzyme services to engineer and produce market-ready enzymes, with Zymtronix expecting to extend into pharma, nutrition, and agriculture markets.Farm ProgressSeed coating shows promise in field trialsZymtronix Catalytic Systems is field-testing a patented enzyme-based seed coating technology designed to reduce bacterial and fungal infections in crops. The company reported up to 20% higher germination rates in laboratory settings and confirmed that the treated seeds are compatible with standard commercial planting equipment during greenhouse trials with Triple P Farms. Agrynex, a spinoff of Zymtronix, is now applying this platform to develop sustainable seed disinfection treatments for various agricultural sectors.SecSEC FORM DZYMtronix, Inc. has filed a notice of exempt offering of securities with the Securities and Exchange Commission. The total offering amount is $2,000,000, with 28 investors participating in the offering to date.WebWireTate & Lyle partners with Zymtronix to leverage novel enzyme immobilization technologiesTate & Lyle announced a partnership with Zymtronix, investing in its enzyme immobilization platform to scale production. The technology, from Cornell University, aims to improve biocatalysis efficiency across food, beverage, and pharmaceutical industries. Tate & Lyle's retired CTO Michael Harrison will join Zymtronix's board.Cornell ChronicleUma Bioseed wins $500,000 in Buffalo competitionUma Bioseed, a startup formed by Cornell University students in partnership with ZYMtronix, won $500,000 at the 43North incubator competition in Buffalo, New York. The company utilizes proprietary enzyme packaging technology from ZYMtronix to produce seed coatings that combat pathogens and increase agricultural yields.